Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2007
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241756 Containing 5-[4-[2[(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt for treating non-insulin dependent diabetes with improved blood glucose regulation without introducing unacceptable side-effects
07/10/2007CA2308850C Inhibitors of gap junction communication
07/05/2007WO2007074753A1 Pharmaceutical comprising substituted urea derivative
07/05/2007WO2007073935A1 Heterocyclic compounds
07/05/2007US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/05/2007US20070155803 Protease inhibitors
07/05/2007US20070155790 Meta-benzamidine derivatives as serine protease inhibitors
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155754 Histamine h3 receptor antagonists, preparation and therapeutic uses
07/05/2007US20070155748 N-sulfonyl-alpha-amino-acid derivatives
07/05/2007US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
07/05/2007US20070155728 Substituted Heterocyclic Compounds
07/05/2007US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/04/2007EP1803706A1 HIV protease inhibitors based on amino acid derivatives
07/04/2007EP1802299A2 Ophthalmic compositions for treating ocular hypertension
07/04/2007CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
07/04/2007CN1993339A Aromatic compounds
07/04/2007CN1993338A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
07/04/2007CN1993337A Method for improving a piperazine colour stability
07/04/2007CN1990471A Mch antagonists and their use in the treatment of obesity
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1324008C Novel compounds and compositions as cathepsin inhibitors
07/03/2007US7238811 Chemical compounds
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007CA2156162C Cancer treatment
06/2007
06/28/2007WO2007072092A2 New phenanthridine derivatives as bradykinin antagonists
06/28/2007WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives
06/28/2007WO2007072041A1 Therapeutic compounds
06/28/2007WO2007071766A2 Phenoxy acetic acids as ppar delta activators
06/28/2007WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/28/2007WO2007071035A1 Heterocyclic amide derivatives as calcium channel blockers
06/28/2007US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives
06/28/2007US20070149562 Oxopiperidine derivatives, preparation and therapeutic use thereof
06/28/2007US20070149545 Substituted indan derivatives
06/28/2007US20070149542 Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007CA2633457A1 Heterocyclic amide derivatives as calcium channel blockers
06/28/2007CA2631390A1 Phenoxy acetic acids as ppar delta activators
06/28/2007CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/27/2007EP1801087A1 Cis-1,2-substituted stilbene derivates and the use thererof for manufacturing medicaments for treating medicaments for treating and/or preventing diabetes
06/27/2007EP1799665A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid
06/27/2007EP1799664A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
06/27/2007EP1799663A1 Modulators of hcv replication
06/27/2007EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases
06/27/2007EP1799627A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents
06/27/2007EP1392667B1 Method for the production of biperidin
06/27/2007CN1989120A Guanidine derivatives and therapeutic uses thereof
06/27/2007CN1989119A 新的苯甲酰脲衍生物 The new benzoyl urea derivatives
06/27/2007CN1989118A Crystalline modifications of n-a-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(l)-phenylalanine-4-ethoxycarbonylpiperazide and/or salts thereof
06/27/2007CN1989106A N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1989099A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
06/27/2007CN1988908A Amido compounds and their use as pharmaceuticals
06/27/2007CN1986535A Synthesis process of roxatidine acetate hydrochloride
06/27/2007CN1986534A Compound containing morpholine cation radical and its synthesis process and use
06/26/2007US7235552 Cholenic acid amides and pharmaceutical compositions thereof
06/26/2007US7235549 Benzamide, heteroarylamide and reverse amides
06/21/2007WO2007070506A2 Diaza heterocyclic sulfonamide derivatives and their uses
06/21/2007WO2007045462A3 Novel vanilloid receptor ligands and their use for producing medicaments
06/21/2007US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide
06/21/2007US20070142229 Agriculture
06/21/2007US20070141659 Sets and Compositions Pertaining to Analyte Determination
06/21/2007CA2632030A1 Compounds which modulate the cb2 receptor
06/21/2007CA2632027A1 Diaza heterocyclic sulfonamide derivatives and their uses
06/20/2007EP1798227A1 Serotonin 5-ht3 receptor agonist
06/20/2007EP1797054A2 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
06/20/2007EP1796466A2 Antibacterial agents
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007CN1984895A Synthesis and uses of synephrine derivatives
06/20/2007CN1984885A Bicyclic aromatic sulfinyl derivatives
06/20/2007CN1984873A Method for the continuous production of an amine
06/20/2007CN1984872A Process for the preparation of an (hetero) arylamine
06/20/2007CN1983490A Dynamic molecular-based electronic device and its operation
06/20/2007CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
06/19/2007US7232926 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative
06/19/2007US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
06/19/2007US7232690 Adding a target to mixture and forming a complex of target and at least one active chemical substance of the mixture,separating the complex from the inactive chemical substances of the mixture, andeitherliberating and isolating and/or identifying at least one active chemical substance
06/14/2007WO2007067575A2 Process for preparing substituted aryl cycloalkanol derivatives
06/14/2007WO2007067501A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
06/14/2007WO2007066163A2 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
06/14/2007WO2007066162A1 Process for the preparation of a pharmaceutical intermediate
06/14/2007WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007WO2007012984A3 Process of producing bepromoline
06/14/2007WO2007006387A8 Onium-alkylsulfonate production method
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors
06/14/2007CA2632212A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007CA2629807A1 Process for preparing substituted aryl cycloalkanol derivatives
06/14/2007CA2629609A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 341